Nemaura Medical to Ring the Nasdaq Closing Bell

LOUGHBOROUGH, England--()--Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system for adjunctive use by persons with diabetes, today announced that Bashir Timol, Director of Strategy and Corporate Development, will ring the closing bell of the Nasdaq Stock Market on Tuesday, March 6, 2018 at 4:00 pm ET.

Mr. Timol will be ringing the bell in honor of the Company’s recent uplisting to the Nasdaq Capital Market.

A live stream of the Nasdaq Closing Bell will be available at:

https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx

About Nemaura Medical, Inc.

Nemaura Medical Inc. (NASDAQ: NMRD), is a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible glucose monitoring system for adjunctive use by persons with diabetes. SugarBEAT® consists of a disposable adhesive skin-patch connected to a rechargeable transmitter, with an app displaying glucose readings. For more information, please visit www.NemauraMedical.com and www.SugarBEAT.com.

Contacts

Nemaura Medical
Bashir Timol
Director of Strategy & Corporate Development
bashir.timol@nemauramedical.com

Recent Stories

RSS feed for Nemaura Medical

Nemaura Medical